← Eichor
Study identifier: NCT06140992 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Condition: Unknown Primary Tumors · DNA Methylation  ·  Sponsor: Sun Yat-sen University

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study aims to initially utilize machine learning on pan-cancer DNA methylation data from public databases to construct a DNA methylation classification model (PaCIFiC-CUP, pan-cancer integrated fingerprinting classifier of CUP) for diagnosing various types of cancer, particularly the primary site of cancer of unknown primary. The goal is to achieve diagnosis of cancer pathology type by analyzing the DNA methylation patterns of cancer specimens, thereby guiding subsequent precision treatment for cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Yiyang Zhang  ·  +8615652797092  ·  zhangyy@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Sun Yat-sen university cancer centerGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06140992